![Sten Randahl Sörensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sten Randahl Sörensen
Vorstandsvorsitzender bei
CERENO SCIENTIFIC AB
Vermögen: 686 127 $ am 31.05.2026
Profil
Sten Randahl Sörensen is currently Chief Executive Officer & Director at Cereno Scientific AB since 2015, Chairman at SARomics Biostructures AB since 2013, and Director at SynAct Pharma AB since 2024.
Former positions include Chairman at AcuCort AB, Chairman at Stayble Therapeutics AB, Director-Secondary Prevention Products Marketing at AstraZeneca AB, and Head-International Marketing Operations at Monsanto Crop Sciences Sweden AB from 1987 to 1995.
Education includes undergraduate studies at the University of Lund.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 1 128 514 ( 0,36 % ) | 653 285 $ | 31.05.2026 | |
SYNACT PHARMA AB 0,03 % | 31.12.2024 | 17 407 ( 0,03 % ) | 32 841 $ | 31.05.2026 |
Aktive Positionen von Sten Randahl Sörensen
| Unternehmen | Position | Beginn |
|---|---|---|
| CERENO SCIENTIFIC AB | Vorstandsvorsitzender | 01.09.2015 |
| SYNACT PHARMA AB | Direktor/Vorstandsmitglied | 20.03.2024 |
SARomics Biostructures AB
 SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Vorsitzender | 01.01.2013 |
Ehemalige bekannte Positionen von Sten Randahl Sörensen
| Unternehmen | Position | Ende |
|---|---|---|
Monsanto Crop Sciences Sweden AB | Vertrieb & Marketing | 01.01.1995 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Vertrieb & Marketing | - |
| STAYBLE THERAPEUTICS AB | Vorsitzender | - |
| ACUCORT AB | Vorsitzender | - |
Ausbildung von Sten Randahl Sörensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monsanto Crop Sciences Sweden AB | |
AcuCort AB
 AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Stayble Therapeutics AB
 Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Wählen Sie MarketScreener 
